Addiction Therapist

Michael Gregory Roffeis

1230 N Marengo Ave, Pasadena, California, 91103-2217

About Michael Gregory Roffeis

Michael Gregory Roffeis is a therapist based in Pasadena, California who is specialized in Addiction (Substance Use Disorder) Counselor. Active license number of Michael Gregory Roffeis is R1545980124 for Addiction (Substance Use Disorder) Counselor in California. His current practice location is 1230 N Marengo Ave, Pasadena. Patients can reach him at 626-797-1124. Michael Gregory Roffeis NPI number (Unique professional ID assigned by NPPES) is 1063241040.

Michael Gregory Roffeis is a licensed mental health therapist who help individuals struggling with addiction of alcohol, drug, or other substance use disorder. He helps his clients by manage and overcome the psychological, emotional, and behavioral challenges related to substance use. Counselors also work closely with families and support systems to help them better understand their loved one’s illness. SUD counselors help to promote long-term sobriety, emotional stability, and overall mental wellness for both the individual and their family.

Practice Information

Michael Gregory Roffeis speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.

Provider Name Michael Gregory Roffeis
Specialization Addiction (Substance Use Disorder) Counselor
Gender Male
Practice Address: 1230 N Marengo Ave,
Pasadena, CA - 91103-2217

Professional Identification Codes

NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.

NPI Number1063241040
NPI Enumeration Date: 29 Jul, 2024
NPI Last Update On: 29 Jul, 2024

Medical Licenses:

Healthcare professionals can hold one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Michael Gregory Roffeis are as mentioned below.

License NumberSpecializationStateStatus
R1545980124Addiction (Substance Use Disorder) Counselor CaliforniaPrimary

Mailing Address

Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned Practice address.

Michael Gregory Roffeis
1230 N Marengo Ave,
Pasadena, CA - 91103-2217
Phone: 626-797-1124

Book an Appointment with Michael Gregory Roffeis

To schedule an appointment, contact Michael Gregory Roffeis at 1230 N Marengo Ave, Pasadena, California or call on below stated phone number.

Call to Book an Appointment

Frequently Asked Questions

Below are some commonly asked questions about Michael Gregory Roffeis:

Michael Gregory Roffeis is a therapist specializing in Addiction (Substance Use Disorder) Counselor. He is a licensed mental health therapist who help individuals struggling with addiction of alcohol, drug, or other substance use disorder. He helps his clients by manage and overcome the psychological, emotional, and behavioral challenges related to substance use. Counselors also work closely with families and support systems to help them better understand their loved one’s illness. SUD counselors help to promote long-term sobriety, emotional stability, and overall mental wellness for both the individual and their family.

Yes, Michael Gregory Roffeis is currently accepting new patients. To schedule an appointment, contact the office directly and schedule an appointment.

Michael Gregory Roffeis practices at 1230 N Marengo Ave, Pasadena, California, 91103-2217.

To schedule an appointment with Michael Gregory Roffeis, please contact the office at 626-797-1124.

Reviews & Feedback

Have you visited Michael Gregory Roffeis? Share your experience to help others looking for a Addiction (Substance Use Disorder) Counselor in Pasadena, CA.

Read Reviews / Give Feedback
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 September, 2026.